Long-term Cardiovascular Safety of Ustekinumab in Psoriasis and Psoriatic Arthritis: Results from an Observational Post-Authorization Safety Study Based on Swedish National Registers - Supplemental material

Supplementary material for the study "Long-term Cardiovascular Safety of Ustekinumab in Psoriasis and Psoriatic Arthritis: Results from an Observational Post-Authorization Safety Study Based on Swedish National Registers"《乌司奴单抗（Ustekinumab）在银屑病与银屑病关节炎中的长期心血管安全性：基于瑞典国家登记系统的观察性上市后安全性研究结果》的补充材料